hold

Broker's Calls

Long-term growth prospects remain intact for ST Engineering

SINGAPORE (May 15): UOB Kay Hian has downgraded ST Engineering from “buy” to “hold” even as it raised its target price to $3.90 from $3.70 previously.

Broker's Calls

StarHub’s unsurprising 1Q results continue to forebode challenges ahead

SINGAPORE (May 4): OCBC Investment Research and UOB Kay Hian are maintaining their “sell” and “hold” recommendations on StarHub at a respective target price of $2.40 and $2.98.

Broker's Calls

Logistics oversupply remains key drag on Mapletree Logistics Trust’s organic fundamentals

SINGAPORE (May 2): Maybank Kim Eng Research continues to rate Mapletree Logistics Trust (MLT) at “hold” at an unchanged price target of $1.20.

Broker's Calls

Potential risks keep UOB at ‘hold’ despite strong 1Q17 results

SINGAPORE (May 2): CIMB Research and OCBC Investment Research have reiterated their “hold” calls on UOB Bank, raising their respective target price and fair value estimates to $21.20 from $20.37 and $21.66 from $20.55 previously.

Broker's Calls

PACC Offshore gets an upgrade amid tough industry times

SINGAPORE (April 12): OCBC has upgraded PACC Offshore Services Holdings (POSH) from “sell” to “hold”, with a higher fair value estimate of 33.5 cents.

Broker's Calls

SingPost put on ‘hold’ in anticipation of new CEO

SINGAPORE (March 27): Maybank Kim Eng Research is maintaining its “hold” call on Singapore Post (SingPost) at an unchanged target price of $1.34 given major decisions within the group are likely to be put on hold until new CEO, Paul Coutts officially

Broker's Calls

SingPost has seen better days, but prospects remain hopeful

SINGAPORE (Nov 8): UOB Kay Hian and OCBC Investment Research have both announced a “hold” recommendation on Singapore Post (SingPost) with a lower target price of $1.76 and a higher fair value of $1.47 respectively.

Broker's Calls

Delfi now a more delectable option to OCBC

SINGAPORE (Sept 22): OCBC Investment Research has upgraded its previous “sell” call on cocoa manufacturer and distributor Delfi to “hold” with an unchanged fair value estimate of $2.34.

Broker's Calls

Lofty valuations mar IHH Healthcare’s new hospital openings

SINGAPORE (July 13): UOB Kay Hian has raised its target price for IHH Healthcare from $2.09 to $2.31 as the company is set to open three more hospital projects, but maintained a “hold” recommendation given the stock’s lofty valuations.
×